TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Polypeptide Laboratories Holding (PPL) AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,756,399
|
1,253,351
|
870,070 |
Financial expenses |
127,086
|
41,217
|
16,895 |
Earnings before taxes |
-336,442
|
-200,295
|
-45,603 |
EBITDA |
-578,497
|
-158,678
|
-17,684 |
Total assets |
4,442,600
|
2,832,010
|
1,975,213 |
Current assets |
1,515,975
|
549,252
|
417,626 |
Current liabilities |
1,326,402
|
803,989
|
809,982 |
Equity capital |
419,736
|
518,080
|
487,391 |
- share capital |
203
|
189
|
180 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
9.4%
|
18.3%
|
24.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
-19.2%
|
-16.0%
|
-5.2% |
Return on assets (ROA) |
-4.7%
|
-5.6%
|
-1.5% |
Current ratio |
114.3%
|
68.3%
|
51.6% |
Return on equity (ROE) |
-80.2%
|
-38.7%
|
-9.4% |
Change turnover |
414,114
|
409,431
|
178,390 |
Change turnover % |
31%
|
49%
|
26% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.